tiprankstipranks
Oramed Pharm Names Avraham Gabay as New CFO
Company Announcements

Oramed Pharm Names Avraham Gabay as New CFO

Don't Miss our Black Friday Offers:

Oramed Pharm (ORMP) just unveiled an update.

Oramed Pharmaceuticals Inc. has announced the appointment of Mr. Avraham Gabay as the new Chief Financial Officer, Treasurer, and Secretary, set to begin on June 18, 2024. Gabay brings a wealth of experience, having previously held financial leadership roles at BiomX Inc., Oravax Inc., and other notable firms. He is also a certified public accountant and a member of the Israeli Bar Association. His compensation includes a monthly salary, bonuses, equity grants, and a company car, all determined by the company’s Board of Directors and Compensation Committee.

For a thorough assessment of ORMP stock, go to TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskOramed Pharmaceuticals Reinforces Scilex Financial Ties
TheFlyOramed announces restructuring of Scilex debt
TheFlyBiotech Alert: Searches spiking for these stocks today
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App